Pharyngitis Treatment Global Market Report 2025

Description

Pharyngitis treatment involves the care and management of individuals who are dealing with inflammation in the oropharynx, commonly referred to as the throat. Pharyngitis can have multiple causes, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and exposure to certain toxins.

The primary classes of drugs used in pharyngitis treatment encompass beta-lactams, macrolides, cephalosporins, fluoroquinolones, tetracyclines, and other categories. Beta-lactams are a class of antibiotics distinguished by the presence of a beta-lactam ring in their chemical structure. Infections can stem from various sources, including viral and bacterial agents. Additionally, treatments are administered through various modes, such as oral, intravenous, intramuscular, and others, catering to diverse end-users, including hospitals, homecare settings, specialty centers, and more.

The pharyngitis treatment market research report is one of a series of new reports from The Business Research Company that provides pharyngitis treatment market statistics, including pharyngitis treatment industry global market size, regional shares, competitors with a pharyngitis treatment market share, detailed pharyngitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the pharyngitis treatment industry. This pharyngitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharyngitis treatment market size has grown steadily in recent years. It will grow from $2.27 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes.

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration,.

The increasing transmission of strep throat is poised to drive the expansion of the pharyngitis treatment market. Strep throat is a contagious bacterial infection primarily affecting the throat and tonsils. Swift and effective treatment of strep throat with antibiotics is crucial for symptom relief, complication prevention, and reducing the risk of spreading the infection to others. For example, as of June 2022, data from the Centers for Disease Control and Prevention, a US-based government agency, reveals an annual occurrence of approximately 14,000 to 25,000 cases of invasive group A strep disease in the United States. Furthermore, strep-related diseases prompt 5.2 million outpatient visits and result in 2.8 million antibiotic prescriptions each year. Thus, the increased transmission of strep throat is a significant driver of growth in the pharyngitis treatment market.

The increasing incidence of influenza is expected to drive the growth of the pharyngitis treatment market. Influenza, commonly referred to as the flu, is a contagious respiratory illness caused by influenza viruses. Pharyngitis treatment is commonly used to manage the symptoms of influenza, including inflammation and irritation of the throat. These treatments are aimed at alleviating discomfort, relieving allergies, and preventing complications such as pneumonia and bronchitis. For example, in July 2023, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported that during the 2022/2023 influenza season in the EU/EEA, the percentage of positive influenza specimens reached 42% in week 51 of 2022, with positivity remaining around 28% from week 5 to week 12 of 2023. As a result, the rising incidence of influenza is driving the growth of the pharyngitis treatment market.

Major companies operating in the pharyngitis treatment market are focusing on developing innovative solutions like oral monotherapy to improve patient compliance and offer effective, convenient treatment options. Oral monotherapy refers to using a single medication administered orally to treat a specific condition, rather than combining multiple treatments. This approach simplifies the treatment regimen while delivering the desired therapeutic effect. For example, in December 2023, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Fabhalta (iptacopan), marking it as the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH). This approval provides a significant advancement by offering a new treatment that enhances hemoglobin levels, removing the need for blood transfusions.

In November 2022, TPG Inc., a US-based private equity firm, acquired a majority stake in iNova Pharmaceuticals for $1.3 billion (USD 2 billion). This acquisition aims to accelerate growth, expand market reach, and enhance product offerings in the healthcare sector, particularly in Southeast and North Asia. iNova Pharmaceuticals, based in Singapore, provides over-the-counter products designed to relieve symptoms of pharyngitis, including throat lozenges and pain relievers.

Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharyngitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharyngitis treatment market consists of sales of antibiotics, antiviral drugs and antifungal medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharyngitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharyngitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharyngitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharyngitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
2) By Source of Infection: Viral; Bacterial
3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Beta Lactams: Penicillins; Amoxicillin; Ampicillin
2) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
3) By Cephalosporins: Cefuroxime; Ceftriaxone; Cefdinir
4) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin
5) By Tetracycline: Doxycycline; Minocycline; Tetracycline
6) By Other Drug Classes: Clindamycin; Sulfonamides; Carbapenems
Companies Mentioned: Pfizer Inc.; GlaxoSmithKline PLC; Genentech Inc.; Pliva Hrvatska D.o.o.; Viatris Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28741

1. Executive Summary

2. Pharyngitis Treatment Market Characteristics

3. Pharyngitis Treatment Market Trends And Strategies

4. Pharyngitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharyngitis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pharyngitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pharyngitis Treatment Market Growth Rate Analysis
5.4. Global Pharyngitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pharyngitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pharyngitis Treatment Total Addressable Market (TAM)

6. Pharyngitis Treatment Market Segmentation

6.1. Global Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta Lactams
Macrolides
Cephalosporins
Fluoroquinolones
Tetracycline
Other Drug Classes
6.2. Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral
Bacterial
6.3. Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Intramuscular
Other Modes Of Delivery
6.4. Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End-Users
6.5. Global Pharyngitis Treatment Market, Sub-Segmentation Of Beta Lactams, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillins
Amoxicillin
Ampicillin
6.6. Global Pharyngitis Treatment Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillins
Amoxicillin
Ampicillin
6.7. Global Pharyngitis Treatment Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cefuroxime
Ceftriaxone
Cefdinir
6.8. Global Pharyngitis Treatment Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ciprofloxacin
Levofloxacin
Moxifloxacin
6.9. Global Pharyngitis Treatment Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Doxycycline
Minocycline
Tetracycline
6.10. Global Pharyngitis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clindamycin
Sulfonamides
Carbapenems

7. Pharyngitis Treatment Market Regional And Country Analysis

7.1. Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharyngitis Treatment Market

8.1. Asia-Pacific Pharyngitis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharyngitis Treatment Market

9.1. China Pharyngitis Treatment Market Overview
9.2. China Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharyngitis Treatment Market

10.1. India Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharyngitis Treatment Market

11.1. Japan Pharyngitis Treatment Market Overview
11.2. Japan Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharyngitis Treatment Market

12.1. Australia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharyngitis Treatment Market

13.1. Indonesia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharyngitis Treatment Market

14.1. South Korea Pharyngitis Treatment Market Overview
14.2. South Korea Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharyngitis Treatment Market

15.1. Western Europe Pharyngitis Treatment Market Overview
15.2. Western Europe Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharyngitis Treatment Market

16.1. UK Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharyngitis Treatment Market

17.1. Germany Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharyngitis Treatment Market

18.1. France Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharyngitis Treatment Market

19.1. Italy Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharyngitis Treatment Market

20.1. Spain Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharyngitis Treatment Market

21.1. Eastern Europe Pharyngitis Treatment Market Overview
21.2. Eastern Europe Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharyngitis Treatment Market

22.1. Russia Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharyngitis Treatment Market

23.1. North America Pharyngitis Treatment Market Overview
23.2. North America Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharyngitis Treatment Market

24.1. USA Pharyngitis Treatment Market Overview
24.2. USA Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharyngitis Treatment Market

25.1. Canada Pharyngitis Treatment Market Overview
25.2. Canada Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharyngitis Treatment Market

26.1. South America Pharyngitis Treatment Market Overview
26.2. South America Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharyngitis Treatment Market

27.1. Brazil Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharyngitis Treatment Market

28.1. Middle East Pharyngitis Treatment Market Overview
28.2. Middle East Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharyngitis Treatment Market

29.1. Africa Pharyngitis Treatment Market Overview
29.2. Africa Pharyngitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharyngitis Treatment Market Competitive Landscape And Company Profiles

30.1. Pharyngitis Treatment Market Competitive Landscape
30.2. Pharyngitis Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pliva Hrvatska D.o.o. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharyngitis Treatment Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.
31.2. AbbVie Inc.
31.3. Medtronic plc
31.4. Takeda Pharmaceutical Company Limited
31.5. Eli Lilly and Company
31.6. Gilead Sciences Inc.
31.7. Amgen Inc.
31.8. Boehringer Ingelheim International GmbH
31.9. Viatris Inc.
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Fresenius Kabi AG
31.12. Bausch Health Companies Inc.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Dr. Reddy's Laboratories Ltd.
31.15. Cipla Limited

32. Global Pharyngitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharyngitis Treatment Market

34. Recent Developments In The Pharyngitis Treatment Market

35. Pharyngitis Treatment Market High Potential Countries, Segments and Strategies

35.1 Pharyngitis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Pharyngitis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Pharyngitis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer